New Paths to Commercialization
Optimal reimbursement, target market access, and pricing are critical challenges for manufacturers, yet commercialization often isn't integrated into clinical and regulatory planning. As a result, many new health treatments fail to achieve their commercial potential. PAREXEL Consulting offers a bold solution in the form of HERON™ Commercialization. Our expertise aligns evidence development and economic evaluation with pricing, reimbursement and market access strategy.
Here you can access the latest articles and resources developed by HERON Commercialization, including exclusive insights on successful approaches to evidence generation that proves asset value to stakeholders.
Check back in the coming weeks to access more new content, including interactive surveys and online events that enable your participation in discussions.
HERON™ Commercialization Overview Brochure
Click here to download our brochure.